Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma

Abstract

Tertiary lymphoid structures (TLS) are ectopic lymphoid structures in cancers that are largely associated with favourable prognosis. However, the prognostic value of TLSs in oral squamous cell carcinoma (OSCC) is largely unknown, and the association between tumour infiltrating lymphocytes (TILs) and TLSs has been rarely explored in OSCC. In this study, associated markers of TLS, including peripheral node address (PNAd) in high endothelial venules, CD20 in B cells and CD3 in T cells, were examined in 168 OSCC patients, and survival analysis was performed between TLS-positive and TLS-negative cohorts. We detected the presence of TILs by staining CD8+ cytotoxic T cells and CD57+ NK cells as well. TLSs appeared as highly organized structures in 45 (26.8%) cases. TLS-positive patients had a better 5-year overall survival (OS) rate (88.9% vs. 56.1%, P < 0.001) and relapse-free survival (RFS) rate (88.9% vs. 63.4%, P = 0.002). Moreover, the presence of TLS was an independent prognostic factor for both the 5-year OS rate (hazard ratio [HR] = 3.784; 95% confidence interval [CI], 1.498–9.562) and RFS rate (HR = 3.296; 95% CI, 1.279–8.490) in multivariate analysis. Furthermore, a higher density of CD8+ T cells and CD57+ NK cells was found in TLS-positive sections than in TLS-negative counterparts (P < 0.001), and their combination provided a higher predictive accuracy (AUC = 0.730; 95% CI, 0.654–0.805). In conclusion, our results suggest that TLS is an independent positive prognostic factor for OSCC patients. These findings provide a theoretical basis for the future diagnostic and therapeutic value of TLSs in OSCC treatment.

References

[1] Bray F, . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin., 2018, 68: 394-424.

[2] Chi AC, Day TA, Neville BW. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J. Clin., 2015, 65: 401-421.

[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J. Clin., 2020, 70: 7-30.

[4] Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science, 2018, 359: 1350-1355.

[5] Ferris RL, . Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N. Engl. J. Med., 2016, 375: 1856-1867.

[6] Pitzalis C, Jones GW, Bombardieri M, Jones SA. Ectopic lymphoid-like structures in infection, cancer and autoimmunity. Nat. Rev. Immunol., 2014, 14: 447-462.

[7] Colbeck EJ, Ager A, Gallimore A, Jones GW. Tertiary lymphoid structures in cancer: drivers of antitumor immunity, immunosuppression, or bystander sentinels in disease?. Front. Immunol., 2017, 8: 1830.

[8] Di Caro G, . Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications. Int. Rev. Immunol., 2015, 34: 123-133.

[9] Sautès-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat. Rev. Cancer, 2019, 19: 307-325.

[10] Dieu-Nosjean MC, Goc J, Giraldo NA, Sautès-Fridman C, Fridman WH. Tertiary lymphoid structures in cancer and beyond. Trends Immunol., 2014, 35: 571-580.

[11] Siliņa K, . Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma. Cancer Res., 2018, 78: 1308-1320.

[12] Cipponi A, . Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res., 2012, 72: 3997-4007.

[13] Di Caro G, . Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin. Cancer Res., 2014, 20: 2147-2158.

[14] Goc J, Fridman WH, Hammond SA, Sautès-Fridman C, Dieu-Nosjean MC. Tertiary lymphoid structures in human lung cancers, a new driver of antitumor immune responses. Oncoimmunology, 2014, 3

[15] Lee HJ, . Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer. J. Clin. Pathol., 2016, 69: 422-430.

[16] Cabrita R, . Tertiary lymphoid structures improve immunotherapy and survival in melanoma. Nature, 2020, 577: 561-565.

[17] Remark R, . Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Clin. Cancer Res., 2013, 19: 4079-4091.

[18] Bento DC, . High endothelial venules are rare in colorectal cancers but accumulate in extra-tumoral areas with disease progression. Oncoimmunology, 2015, 4

[19] Wirsing AM, Rikardsen OG, Steigen SE, Uhlin-Hansen L, Hadler-Olsen E. Characterisation and prognostic value of tertiary lymphoid structures in oral squamous cell carcinoma. BMC Clin. Pathol., 2014, 14

[20] Badalamenti G, . Role of tumor-infiltrating lymphocytes in patients with solid tumors: can a drop dig a stone?. Cell. Immunol., 2019, 343: 103753.

[21] Schweiger T, . Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer. Clin. Exp. Metastasis, 2016, 33: 727-739.

[22] Kroeger DR, Milne K, Nelson BH. Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer. Clin. Cancer Res., 2016, 22: 3005-3015.

[23] Fang J, . Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer, 2017, 17

[24] Huntington ND, Cursons J, Rautela J. The cancer–natural killer cell immunity cycle. Nat. Rev. Cancer, 2020, 20: 437-454.

[25] Farhood B, Najafi M, Mortezaee K. CD8⁺ cytotoxic T lymphocytes in cancer immunotherapy: a review. J. Cell. Physiol., 2019, 234: 8509-8521.

[26] Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol., 2013, 14: 1014-1022.

[27] Martinet L, . Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res., 2011, 71: 5678-5687.

[28] Hiraoka N, . Intratumoral tertiary lymphoid organ is a favourable prognosticator in patients with pancreatic cancer. Br. J. Cancer, 2015, 112: 1782-1790.

[29] Coppola D, . Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am. J. Pathol., 2011, 179: 37-45.

[30] Goc J, . Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8⁺ T cells. Cancer Res., 2014, 74: 705-715.

[31] Lee M, . Presence of tertiary lymphoid structures determines the level of tumor-infiltrating lymphocytes in primary breast cancer and metastasis. Mod. Pathol., 2019, 32: 70-80.

[32] Helmink BA, . B cells and tertiary lymphoid structures promote immunotherapy response. Nature, 2020, 577: 549-555.

[33] Hiraoka N, Ino Y, Yamazaki-Itoh R. Tertiary lymphoid organs in cancer tissues. Front. Immunol., 2016, 7: 244.

[34] Jansen CS, . An intra-tumoral niche maintains and differentiates stem-like CD8 T cells. Nature, 2019, 576: 465-470.

[35] Figenschau SL, Fismen S, Fenton KA, Fenton C, Mortensen ES. Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients. BMC Cancer, 2015, 15

[36] Dieu-Nosjean MC, . Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers. Immunol. Rev., 2016, 271: 260-275.

[37] Workel HH, . A transcriptionally distinct CXCL13⁺ CD103⁺ CD8⁺ T-cell population is associated with B-cell recruitment and neoantigen load in human cancer. Cancer Immunol. Res., 2019, 7: 784-796.

[38] Li K, . Oral cancer-associated tertiary lymphoid structures: gene expression profile and prognostic value. Clin. Exp. Immunol., 2020, 199: 172-181.

[39] Ruddle NH. High endothelial venules and lymphatic vessels in tertiary lymphoid organs: characteristics, functions, and regulation. Front. Immunol., 2016, 7: 491.

[40] Ager A, May MJ. Understanding high endothelial venules: lessons for cancer immunology. Oncoimmunology, 2015, 4

[41] Matsumoto H, . Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Res. Treat., 2016, 156: 237-247.

[42] Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat. Rev. Immunol., 2002, 2: 957-964.

[43] Zhang Q, . Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell, 2019, 179: 829-845.e20.

[44] Jacobs B, Ullrich E. The interaction of NK cells and dendritic cells in the tumor environment: how to enforce NK cell & DC action under immunosuppressive conditions?. Curr. Med. Chem., 2012, 19: 1771-1779.

[45] Germain C, Gnjatic S, Dieu-Nosjean MC. Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity. Front. Immunol., 2015, 6: 67.

[46] Sautès-Fridman C, . Tertiary lymphoid structures in cancers: prognostic value, regulation, and manipulation for therapeutic intervention. Front. Immunol., 2016, 7: 407.

[47] Petitprez F, . B cells are associated with survival and immunotherapy response in sarcoma. Nature, 2020, 577: 556-560.